Showing results (421-430 of 464) with videos related to

Sort By:
Pageof 47
Scientific Reports|October 19, 2016
Notch fatigue behavior: Metallic glass versus ultra-high strength steelX D Wang, R T Qu, S J Wu, et al.
Cancer Research|April 1, 1997
Cooperative effects of p53 and pRB alterations in primary superficial bladder tumorsC Cordon-Cardo, Z F Zhang, G Dalbagni, et al.
Journal of the National Cancer Institute|October 18, 1995
Deletion of the p16 and p15 genes in human bladder tumorsI Orlow, L Lacombe, G J Hannon, et al.
Journal of the National Cancer Institute|February 26, 1999
Post-therapy serum prostate-specific antigen level and survival in patients with androgen-independent prostate cancerH I Scher, W M Kelly, Z F Zhang, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|January 1, 1994
Tobacco smoking, occupation, and p53 nuclear overexpression in early stage bladder cancerZ F Zhang, A S Sarkis, C Cordon-Cardo, et al.
Journal of Dairy Science|September 14, 2020
A novel risk assessment tool for bovine respiratory disease in preweaned dairy calvesG U Maier, W J Love, B M Karle, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|April 1, 1996
Familial and nutritional risk factors for p53 overexpression in colorectal cancerA N Freedman, A M Michalek, J R Marshall, et al.
Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association for Cancer Research, Cosponsored by the American Society of Preventive Oncology|July 7, 2001
Inverse associations between plasma lycopene and other carotenoids and prostate cancerQ Y Lu, J C Hung, D Heber, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1995
Prognostic value of p53 nuclear overexpression in patients with invasive bladder cancer treated with neoadjuvant MVACA S Sarkis, D F Bajorin, V E Reuter, et al.
Pageof 47